《大行報告》花旗微降信置(00083.HK)目標價至9.1元 股息率7.1%評級「買入」
花旗發表報告指出,信置(00083.HK)手頭現金高達433億元,股價被低估。雖然該行預期由於需求疲弱,影響公司香港發展利潤及寫字樓收入,但有關的負面影響將被高利息環境下,強勁淨現金狀況產生的更高利息收入而部分抵銷。
該行認為,儘管信置盈利下降,但由於管理層承諾無論盈利如何波動下都會穩步提高派息率政策,因此該行預期2024財年每股派息將增長2%。然而,隨著利率見頂,對其投資理論略為受損,投資者並無立即持有信置的理由。該行維持對信置的「買入」評級,指現財年股息率料約7.1%,目標價由9.2元輕微下調至9.1元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.